From: Screening for sickle cell disease in newborns: a systematic review
Study | Study design | Investigated newborns (intervention/control) | Number of newborns with SCD | Place and period of recruitment | Intervention/control | Main inclusion criteria | Patient-relevant endpoints | Funding source |
---|---|---|---|---|---|---|---|---|
King et al. [26] | Retrospective controlled cohort study | Intervention group: 150,803 | 435a (SCD-S/S) | Jamaica Victoria Jubilee Hospital, Kingston, 11/1995–07/2006 University Hospital of the West Indies, Kingston, 10/1997–07/2006 Spanish Town Hospital, St. Catherine, 04/1998–07/2006 | - Screening of live newborns for SCD - In the case of diagnosis of an SCD initial consultation and education programme - If possible, parents will receive a newborn first consultation at the clinic before the 4th month of life - Guidance of the parents on how to perform a splenic palpation - From the 4th month of life penicillin prophylaxis - Every 3 months routine examination in clinic, every 6 months after 5 years of age | - Consecutive live newborns - Screening of umbilical cord blood indicates SCD-S/S phenotype - Confirmation diagnostics confirmed SCD-S/S (electrophoresis) | Mortality in 1st, 2nd, 3rd, 5th, and 10th year of lifeb | Not stated |
Control groupc: approx. 30,000 | 105 (SCD-S/S) | Jamaica Victoria Jubilee Hospital, Kingston, 06/1973–12/1975 | -Screening of all live newborns for SCD -Follow-up every 3 months |